Loxo Oncology, Inc. is a biopharmaceutical company. It develops targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Loxo Oncology, Inc. is headquartered in Stamford, Connecticut.
technical indicators:
- 73.47+ Weighted Alpha
- Trend Spotter buy signal
- Above its 20, 50 and 100 day moving averages
- 3 new highs and up 3.15% in the last month
- Relative Strength Index 66.39%
- Barchart computes a technical support level at 20.48
- Recently traded at 22.61 with a 50 day moving average of 19.20
- Market Cap $377.36 million
- Revenue expected to grow 36.90% this year
- Although Wall Street analysts did not post complete Revenue and Earnings projections they still released 2 strong buy and 2 buy recommendations on the stock
- The individual investors on Motley Fool voted 4 to 1 that the stock will beat the market
No comments:
Post a Comment